Manel Cascalló

General Director EU Subsidiary & Founder · Theriva Biologics · company speakers →

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Orphan Drugs & Rare Diseases Global Congress Europe

19 March 2025 London, United Kingdom “VCN-01 oncolytic adenovirus development in pediatric retinoblastoma”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →